Withdrawal of Registration Statement (rw)
June 13 2019 - 3:31PM
Edgar (US Regulatory)
ContraVir Pharmaceuticals, Inc.
399 Thornall Street
Edison, NJ 08837
VIA EDGAR
United States Securities
and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Dorrie Yale
Re:
ContraVir Pharmaceuticals, Inc.
Form S-1, as amended
File No. 333-231604
Dear Ms. Yale:
ContraVir Pharmaceuticals, Inc. (the Company) hereby respectfully withdraws its request, dated June 12, 2019, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Thursday, June 13, 2019. The Company intends to submit a revised acceleration request at a later date.
Please contact Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 if there are any questions with respect to this request.
|
Thank you,
|
|
|
|
CONTRAVIR PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
By:
|
/s/ Robert Foster
|
|
Name:
|
Robert Foster
|
|
Title:
|
Chief Executive Officer
|
Contravir Pharmaceuticals Inc (NASDAQ:CTRV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Contravir Pharmaceuticals Inc (NASDAQ:CTRV)
Historical Stock Chart
From Apr 2023 to Apr 2024